Account
Mankind Pharma’s Gas-o-Fast appoints Tilt Brand Solutions as its AOR
Mumbai: Antacid brand, Gas-o-Fast from Mankind Pharma’s stable has brought on board Mumbai-based brand and communication consultancy, Tilt Brand Solutions as its strategic & creative Agency on Record (AOR).
Gas-o-Fast has seen a 100 per cent growth in varied markets, the company stated, with the average sale of Gas-O-Fast sachets approximately over 1 crore every month. And with more and more consumers showing their inclination towards ayurvedic remedies against acidity, gas, and indigestion, the brand is very optimistic about its future.
“We as a brand are entering into a very critical phase of our growth,” said Mankind Pharma, general manager – sales & marketing Joy Chatterjee. “With our new product innovations lined up in the coming future, we now need a breakthrough differentiation at a brand level which will allow us an unfair advantage in the consumers’ mind. This will be critical for our growth plans in the coming future and we are convinced that Tilt Brand Solutions would be the perfect partner for us going forward. Their planning process is sharp and contemporary, and the body of work put out by them thus far, consistently impressive.”
“This is a very interesting brand and the Mankind team is a very passionate and focussed bunch,” said Tilt Brand Solutions co-founder & chief business officer Rajiv Chatterjee. “Their drive, self-belief, and ambition epitomise the very kind of brands we love partnering with. We are convinced in Gas-o Fast’s rightful ambition to grow and lead the category as also in our ability to bring to bear on this journey, our competencies in data-led in sighting, consumer behaviour, cultural understanding, and impactful storytelling.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
